Skip to main content
Clinical Trials/NCT03499015
NCT03499015UnknownNot Applicable

Balloon Dilation of the Eustachian Tube in Children: a Randomized Side-controlled Clinical Trial

Medical University of Vienna2 sites in 1 country50 target enrollmentStarted: December 14, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
50
Locations
2
Primary Endpoint
Tympanometry-Change (Middle ear effusion/eardrum mobility assessed with Tympanometry)

Study Overview

Brief Summary

Otitis media with effusion (OME) is very common in children and characterized by fluid in the middle ear without signs or symptoms of acute ear infection. Treatment options are tympanostomy tubes and/or adenoidectomy. However OME often reoccurs after these procedures.

Goal of this study will be to evaluate the Balloon Eustachian Tuboplasty (BET) in children as an additional treatment option and to assess long-term effects of BET. Beside the standard procedure, children (4 to 10 years of age), with equal pathology on both ears, will be assigned for BET on side.

Detailed Description

Introduction

Otitis media with effusion (OME, "glue ear") is very common in children and characterized by fluid in the middle ear without signs or symptoms of acute ear infection. Fluid in the middle ear causes conducting hearing loss. OME has a large impact on health care costs and recurrent or persistent OME can effect the proper development of children. Frequently OME resolves itself, therefore guidelines strongly recommend watchful waiting for 3 months after which treatment options are tympanostomy tubes and/or adenoidectomy. However OME often reoccurs after these procedures. Furthermore there are various short and longterm side-effects of tympanostomy tubes.In Balloon Eustachian Tuboplasty (BET) a ballon catheter is used to dilate the cartilage part of the eustachian tube and is inserted through the nose to reach the opening of the tube, located in the nasopharynx. BET has recently been applied in children for therapy-resistant recurrent OME and inflammatory ear diseases with promising results. Risk and complications rates are very low.

Methods:

Goal of this study will be the evaluation of Balloon Eustachian Tuboplasty (BET) in children as a primary treatment of OME. Children between the ages of 4 and 10 years with OME and tympanometry type B on both ears, will prospectively be recruited and assigned for adenoidectomy and myringotomy. Parents then will be asked for participation in this trial and fully informed about purpose, technique and possible side effects. If consent is given, adenoidectomy, in case of large adenoids, and myringotomy will be performed on both sides. If necessary (very thick fluid) tympanostomy tubes are placed. One Eustachian tube of each patient is randomly assigned for BET.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Masking Description

only surgeon knows treated side, documentation of side only visible to surgeon and investigator

Eligibility Criteria

Ages
4 Years to 10 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • OME on both sides measured by flat tympanometry

Exclusion Criteria

  • Patients with cleft lip and/or palate and other severe craniofacial abnormalities

Arms & Interventions

Ear without BET

No Intervention

ear without BET treatment works as control

BET ear

Experimental

ear with BET treatment works as intervention arm

Intervention: Balloon Eustachian Tuboplasty (BET) (Procedure)

Outcomes

Primary Outcomes

Tympanometry-Change (Middle ear effusion/eardrum mobility assessed with Tympanometry)

Time Frame: up to 3 months preoperatively and change to 3, 6 and 9 months postoperatively;

Tympanometry, an objective test of middle-ear function, uses variations of air pressure in the ear canal to assess for middle ear effusion / eardrum mobility.

Secondary Outcomes

  • Otoscopy score(up to 3 months preoperatively and change to 3, 6 and 9 months postoperatively;)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christoph Arnoldner

Assoc. Prof. PD M.D.

Medical University of Vienna

Study Sites (2)

Loading locations...

Similar Trials